Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-03-13 Purchase | 2024-03-14 08:45 am | CorMedix Inc. | CRMD | Todisco Joseph Chief Executive Officer | 13,561 | $3.74 | $50,718 | 352,839 (Direct) | View |
| 2023-09-08 Purchase | 2023-09-08 4:21 pm | CorMedix Inc. | CRMD | Todisco Joseph Chief Executive Officer | 10,000 | $3.71 | $37,100 | 219,726 (Direct) | View |
| 2023-05-17 Purchase(A) | 2023-05-18 4:49 pm | CorMedix Inc. | CRMD | Todisco Joseph Chief Executive Officer | 5,000 | $4.58 | $22,900 | 209,726 (Direct) | View |
| 2022-11-15 Purchase | 2022-11-16 4:56 pm | CorMedix Inc. | CRMD | Todisco Joseph Chief Executive Officer | 20,000 | $3.82 | $76,400 | 242,169 (Direct) | View |
| 2022-08-24 Purchase | 2022-08-25 08:37 am | CorMedix Inc. | CRMD | Todisco Joseph Chief Executive Officer | 4,700 | $3.92 | $18,424 | 222,169 (Direct) | View |
| 2022-05-16 Purchase | 2022-05-17 08:30 am | CorMedix Inc. | CRMD | Todisco Joseph Chief Executive Officer | 10,000 | $3.38 | $33,800 | 424,938 (Direct) | View |
| 2021-12-02 Sale | 2021-12-03 6:19 pm | Amneal Pharmaceuticals Inc. | AMRX | Todisco Joseph Executive Vice President | 1,500 | $4.1 | $6,150 | 281,319 (Direct) | View |
| 2021-03-15 Sale | 2021-03-17 4:05 pm | Amneal Pharmaceuticals Inc. | AMRX | Todisco Joseph Executive Vice President | 36,330 | $6.8226 | $247,865 | 316,271 (Direct) | View |
| 2020-02-28 Purchase | 2020-03-03 7:26 pm | Amneal Pharmaceuticals Inc. | AMRX | Todisco Joseph SVP, Specialty Commercial | 40,000 | $3.62 | $144,800 | 285,127 (Direct) | View |
| 2019-05-13 Purchase | 2019-05-13 5:27 pm | Amneal Pharmaceuticals Inc. | AMRX | Todisco Joseph SVP, Specialty Commercial | 15,000 | $9.88 | $148,200 | 205,590 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-01-12 Tax Withholding | 2024-01-17 8:04 pm | N/A N/A | CorMedix Inc. | CRMD | Todisco Joseph Chief Executive Officer | 13,781 | $3.47 | 605,945 (Direct) | View |
| 2024-01-12 Option Award | 2024-01-17 8:04 pm | N/A 2034-01-11 | CorMedix Inc. | CRMD | Todisco Joseph Chief Executive Officer | 400,000 | $0 | 605,945 (Direct) | View |
| 2023-05-17 Option Award | 2023-05-17 5:35 pm | N/A N/A | CorMedix Inc. | CRMD | Todisco Joseph Chief Executive Officer | 5,000 | $4.58 | 209,726 (Direct) | View |
| 2023-05-10 Tax Withholding | 2023-05-12 6:16 pm | N/A N/A | CorMedix Inc. | CRMD | Todisco Joseph Chief Executive Officer | 37,443 | $5.3 | 204,726 (Direct) | View |
| 2023-01-14 Option Award | 2023-01-18 7:04 pm | N/A 2033-01-14 | CorMedix Inc. | CRMD | Todisco Joseph Chief Executive Officer | 400,000 | $0 | 642,169 (Direct) | View |
| 2022-05-10 Option Award | 2022-05-12 4:30 pm | N/A 2032-05-09 | CorMedix Inc. | CRMD | Todisco Joseph Chief Executive Officer | 707,469 | $0 | 707,469 (Direct) | View |
| 2022-05-07 Exercise | 2022-05-10 6:58 pm | N/A N/A | Amneal Pharmaceuticals Inc. | AMRX | Todisco Joseph Executive Vice President | 4,442 | $0 | 327,194 (Direct) | View |
| 2022-05-07 Tax Withholding | 2022-05-10 6:58 pm | N/A N/A | Amneal Pharmaceuticals Inc. | AMRX | Todisco Joseph Executive Vice President | 1,562 | $3.4 | 327,194 (Direct) | View |
| 2022-03-01 Tax Withholding | 2022-03-03 9:22 pm | N/A N/A | Amneal Pharmaceuticals Inc. | AMRX | Todisco Joseph Executive Vice President | 13,237 | $4.45 | 849,843 (Direct) | View |
| 2022-03-03 Option Award | 2022-03-03 9:22 pm | N/A N/A | Amneal Pharmaceuticals Inc. | AMRX | Todisco Joseph Executive Vice President | 434,784 | $0 | 849,843 (Direct) | View |
| 2022-03-01 Exercise | 2022-03-03 9:22 pm | N/A N/A | Amneal Pharmaceuticals Inc. | AMRX | Todisco Joseph Executive Vice President | 37,655 | $0 | 849,843 (Direct) | View |
| 2022-02-27 Tax Withholding | 2022-03-01 5:12 pm | N/A N/A | Amneal Pharmaceuticals Inc. | AMRX | Todisco Joseph Executive Vice President | 11,107 | $4.59 | 359,263 (Direct) | View |
| 2022-02-27 Exercise | 2022-03-01 5:12 pm | N/A N/A | Amneal Pharmaceuticals Inc. | AMRX | Todisco Joseph Executive Vice President | 29,684 | $0 | 359,263 (Direct) | View |
| 2021-05-07 Exercise | 2021-05-11 2:56 pm | N/A N/A | Amneal Pharmaceuticals Inc. | AMRX | Todisco Joseph Executive Vice President | 4,441 | $0 | 287,261 (Direct) | View |
| 2021-05-07 Tax Withholding | 2021-05-11 2:56 pm | N/A N/A | Amneal Pharmaceuticals Inc. | AMRX | Todisco Joseph Executive Vice President | 1,562 | $5.2 | 287,261 (Direct) | View |
| 2021-03-15 Exercise | 2021-03-17 4:05 pm | N/A N/A | Amneal Pharmaceuticals Inc. | AMRX | Todisco Joseph Executive Vice President | 36,330 | $2.75 | 316,271 (Direct) | View |
| 2021-03-15 Exercise | 2021-03-17 4:05 pm | N/A 2028-05-07 | Amneal Pharmaceuticals Inc. | AMRX | Todisco Joseph Executive Vice President | 36,330 | $0 | 316,271 (Direct) | View |
| 2021-03-01 Option Award | 2021-03-03 5:06 pm | N/A N/A | Amneal Pharmaceuticals Inc. | AMRX | Todisco Joseph Executive Vice President | 318,534 | $0 | 318,534 (Direct) | View |
| 2021-02-27 Tax Withholding | 2021-03-02 4:39 pm | N/A N/A | Amneal Pharmaceuticals Inc. | AMRX | Todisco Joseph Executive Vice President | 10,972 | $5.39 | 391,213 (Direct) | View |
| 2021-02-27 Exercise | 2021-03-02 4:39 pm | N/A N/A | Amneal Pharmaceuticals Inc. | AMRX | Todisco Joseph Executive Vice President | 40,794 | $0 | 391,213 (Direct) | View |
| 2021-03-01 Tax Withholding | 2021-03-02 4:39 pm | N/A N/A | Amneal Pharmaceuticals Inc. | AMRX | Todisco Joseph Executive Vice President | 3,906 | $5.18 | 391,213 (Direct) | View |
| 2020-05-07 Tax Withholding | 2020-05-08 7:11 pm | N/A N/A | Amneal Pharmaceuticals Inc. | AMRX | Todisco Joseph SVP, Specialty Commercial | 2,212 | $3.55 | 262,907 (Direct) | View |
| 2020-05-07 Exercise | 2020-05-08 7:11 pm | N/A N/A | Amneal Pharmaceuticals Inc. | AMRX | Todisco Joseph SVP, Specialty Commercial | 4,442 | $0 | 262,907 (Direct) | View |
| 2020-03-01 Tax Withholding | 2020-03-03 7:26 pm | N/A N/A | Amneal Pharmaceuticals Inc. | AMRX | Todisco Joseph SVP, Specialty Commercial | 6,162 | $3.85 | 285,127 (Direct) | View |
| 2020-03-01 Exercise | 2020-03-03 7:26 pm | N/A N/A | Amneal Pharmaceuticals Inc. | AMRX | Todisco Joseph SVP, Specialty Commercial | 11,111 | $0 | 285,127 (Direct) | View |
| 2020-02-27 Option Award | 2020-03-02 8:19 pm | N/A N/A | Amneal Pharmaceuticals Inc. | AMRX | Todisco Joseph SVP, Specialty Commercial | 356,202 | $0 | 356,202 (Direct) | View |
Ownership | 2020-02-14 4:27 pm | N/A N/A | Amneal Pharmaceuticals Inc. | AMRX | Todisco Joseph SVP, Specialty Commercial | 0 | $0 | 189,632 (Direct) | View |
| 2019-11-13 Disposition | 2019-11-14 5:27 pm | N/A 2028-05-07 | Amneal Pharmaceuticals Inc. | AMRX | Todisco Joseph SVP, Specialty Commercial | 163,159 | $0 | 163,159 (Direct) | View |
| 2019-11-13 Option Award | 2019-11-14 5:27 pm | N/A 2028-05-07 | Amneal Pharmaceuticals Inc. | AMRX | Todisco Joseph SVP, Specialty Commercial | 163,159 | $0 | 163,159 (Direct) | View |
| 2019-05-07 Exercise | 2019-05-09 5:45 pm | N/A N/A | Amneal Pharmaceuticals Inc. | AMRX | Todisco Joseph SVP, Specialty Commercial | 4,441 | $0 | 203,915 (Direct) | View |
| 2019-05-07 Tax Withholding | 2019-05-09 5:45 pm | N/A N/A | Amneal Pharmaceuticals Inc. | AMRX | Todisco Joseph SVP, Specialty Commercial | 2,228 | $13.44 | 203,915 (Direct) | View |
Ownership | 2019-05-07 6:12 pm | N/A N/A | Amneal Pharmaceuticals Inc. | AMRX | Todisco Joseph SVP, Specialty Commercial | 0 | $0 | 413,746 (Direct) | View |